Lifeboat Foundation

CIPhotos/iStock.

Standard immunotherapy procedures also employ intravenous injections loaded with NK cells to treat cancer but several limitations with this approach prevent it from delivering satisfying results. For instance, many NK cells lose their viability during the therapy and often fail to target the tumors, according to the researchers.